ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has selected the Oracle Health Sciences LabPas solution, delivered ...

Recent share price weakness is due to temporary headwinds, including client cost-cutting and delays in biotech decision-making, not structural issues in the CRO industry. Long-term prospects remain ...

Understanding what’s happening at Icon Aircraft today demands a quick look at continuous quality improvement, a culture-driven process widely used in automobile manufacturing to help companies manage ...